0001209191-16-098272.txt : 20160212 0001209191-16-098272.hdr.sgml : 20160212 20160212194631 ACCESSION NUMBER: 0001209191-16-098272 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160210 FILED AS OF DATE: 20160212 DATE AS OF CHANGE: 20160212 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: QUIDEL CORP /DE/ CENTRAL INDEX KEY: 0000353569 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 942573850 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 12544 HIGH BLUFF DRIVE STREET 2: SUITE 200 CITY: SAN DIEGO STATE: CA ZIP: 92130 BUSINESS PHONE: 8585521100 MAIL ADDRESS: STREET 1: 12544 HIGH BLUFF DRIVE STREET 2: SUITE 200 CITY: SAN DIEGO STATE: CA ZIP: 92130 FORMER COMPANY: FORMER CONFORMED NAME: MONOCLONAL ANTIBODIES INC /DE/ DATE OF NAME CHANGE: 19910210 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Abney Michael Donald Jr. CENTRAL INDEX KEY: 0001631320 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-10961 FILM NUMBER: 161422096 MAIL ADDRESS: STREET 1: 12544 HIGH BLUFF DRIVE STREET 2: SUITE 200 CITY: SAN DIEGO STATE: CA ZIP: 92130 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2016-02-10 0 0000353569 QUIDEL CORP /DE/ QDEL 0001631320 Abney Michael Donald Jr. 12544 HIGH BLUFF DRIVE, SUITE 200 SAN DIEGO CA 92130 0 1 0 0 SVP - Distribution Non-Qualified Stock Options 15.40 2016-02-10 4 A 0 35192 0.00 A 2026-02-10 Common Stock 35192 35192 D Restricted Stock Units 2016-02-10 4 A 0 4805 0.00 A Common Stock 4805 4805 D 17,596 shares will vest on the second anniversary date of the grant date, February 10, 2018. 8,798 shares will vest on the third anniversary date of the grant date, February 10, 2019. 8,798 shares will vest on the fourth anniversary date of the grant date, February 10, 2020. Each restricted stock unit represents the right to receive one share of Quidel Corporation common stock. 2,403 shares will vest on the second anniversary date of the grant date, February 10, 2018. 1,201 shares will vest on the third anniversary date of the grant date, February 10, 2019. 1,201 shares will vest on the fourth anniversary date of the grant date, February 10, 2020. Robert J. Bujarski, attorney-in-fact for Michael D. Abney, Jr. 2016-02-12